Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent

Lung cancer (LC) is a leading cause of mortality, claiming more than 1.8 million deaths per year worldwide. Surgery is one of the most effective treatments when the disease is in its early stages. The study of metabolic alterations after surgical intervention with curative intent could be used to as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saida Sánchez Espirilla, Antonio Pereira‐Vega, Belén Callejón‐Leblic, Isabel Díaz-Olivares, Rafael Santos Santana, Carolina Gotera Rivera, José Luis Gómez‐Ariza, José Luís López-Campos, Ana Isabel Blanco-Orozco, Luis Seijó, María Teresa Nava Rodríguez, Luis Alejandro Padrón Fraysse, Ángeles Herrera-Chilla, Germán Peces‐Barba, Tamara García‐Barrera
Formato: Artículo
Lenguaje:inglés
Publicado: 2023
Materias:
Acceso en línea:Ver en el sistema de origen
Enlace permanente (DOI o Handle)
Enlace permanente (DOI o Handle)
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1881508931790962688
author Saida Sánchez Espirilla
Antonio Pereira‐Vega
Belén Callejón‐Leblic
Isabel Díaz-Olivares
Rafael Santos Santana
Carolina Gotera Rivera
José Luis Gómez‐Ariza
José Luís López-Campos
Ana Isabel Blanco-Orozco
Luis Seijó
María Teresa Nava Rodríguez
Luis Alejandro Padrón Fraysse
Ángeles Herrera-Chilla
Germán Peces‐Barba
Tamara García‐Barrera
author_browse Ana Isabel Blanco-Orozco
Antonio Pereira‐Vega
Belén Callejón‐Leblic
Carolina Gotera Rivera
Germán Peces‐Barba
Isabel Díaz-Olivares
José Luis Gómez‐Ariza
José Luís López-Campos
Luis Alejandro Padrón Fraysse
Luis Seijó
María Teresa Nava Rodríguez
Rafael Santos Santana
Saida Sánchez Espirilla
Tamara García‐Barrera
Ángeles Herrera-Chilla
author_facet Saida Sánchez Espirilla
Antonio Pereira‐Vega
Belén Callejón‐Leblic
Isabel Díaz-Olivares
Rafael Santos Santana
Carolina Gotera Rivera
José Luis Gómez‐Ariza
José Luís López-Campos
Ana Isabel Blanco-Orozco
Luis Seijó
María Teresa Nava Rodríguez
Luis Alejandro Padrón Fraysse
Ángeles Herrera-Chilla
Germán Peces‐Barba
Tamara García‐Barrera
author_sort Saida Sánchez Espirilla
collection Producción científica
description Lung cancer (LC) is a leading cause of mortality, claiming more than 1.8 million deaths per year worldwide. Surgery is one of the most effective treatments when the disease is in its early stages. The study of metabolic alterations after surgical intervention with curative intent could be used to assess the response to treatment or the detection of cancer recurrence. In this study, we have evaluated the metabolomic profile of serum samples (n = 110) from preoperative (PRE) and postoperative (POST) LC patients collected at two different time points (1 month, A; 3–6 months, B) with respect to healthy people. An untargeted metabolomic platform based on reversed phase (RP) and hydrophilic interaction chromatography (HILIC), using ultra-high performance liquid chromatography (UHPLC) and mass spectrometry (MS), was applied (MassIVE ID MSV000092213). Twenty-two altered metabolites were annotated by comparing all the different studied groups. DG(14,0/22:1), stearamide, proline, and E,e-carotene-3,3′-dione were found altered in PRE, and their levels returned to those of a baseline control group 3–6 months after surgery. Furthermore, 3-galactosyllactose levels remained altered after intervention in some patients. This study provides unique insights into the metabolic profiles of LC patients after surgery at two different time points by combining complementary analytical methods.
format Article
id oai:cris.upeu.edu.pe:20.500.15037/1364
institution UPeU
language English
publishDate 2023
publishDateRange 2023
publishDateSort 2023
record_format dspace
spelling oai:cris.upeu.edu.pe:20.500.15037/13642026-10-30T16:15:39ZUntargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative IntentSaida Sánchez EspirillaAntonio Pereira‐VegaBelén Callejón‐LeblicIsabel Díaz-OlivaresRafael Santos SantanaCarolina Gotera RiveraJosé Luis Gómez‐ArizaJosé Luís López-CamposAna Isabel Blanco-OrozcoLuis SeijóMaría Teresa Nava RodríguezLuis Alejandro Padrón FraysseÁngeles Herrera-ChillaGermán Peces‐BarbaTamara García‐BarreraMetabolomicsLung cancerMedicineHydrophilic interaction chromatographyCancerInternal medicineGastroenterologySurgeryHigh-performance liquid chromatographyBioinformaticsChromatographyChemistryBiologyMetabolomicsLung cancerMedicineHydrophilic interaction chromatographyCancerInternal medicineGastroenterologySurgeryHigh-performance liquid chromatographyBioinformaticsChromatographyChemistryBiologyHumansHumansHumansLung Neoplasms diagnosisLung Neoplasms diagnosisLung Neoplasms diagnosisLung Neoplasms surgeryLung Neoplasms surgeryLung Neoplasms surgeryNeoplasm Recurrence, LocalNeoplasm Recurrence, LocalNeoplasm Recurrence, LocalMass Spectrometry methodsMass Spectrometry methodsMass Spectrometry methodsMetabolomics methodsMetabolomics methodsMetabolomics methodsMetabolomeMetabolomeMetabolomeLife Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Metabolomics and Mass Spectrometry StudiesLife Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Hypoxia, and MetabolismLife Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Lipids, and MetabolismLung cancer (LC) is a leading cause of mortality, claiming more than 1.8 million deaths per year worldwide. Surgery is one of the most effective treatments when the disease is in its early stages. The study of metabolic alterations after surgical intervention with curative intent could be used to assess the response to treatment or the detection of cancer recurrence. In this study, we have evaluated the metabolomic profile of serum samples (n = 110) from preoperative (PRE) and postoperative (POST) LC patients collected at two different time points (1 month, A; 3–6 months, B) with respect to healthy people. An untargeted metabolomic platform based on reversed phase (RP) and hydrophilic interaction chromatography (HILIC), using ultra-high performance liquid chromatography (UHPLC) and mass spectrometry (MS), was applied (MassIVE ID MSV000092213). Twenty-two altered metabolites were annotated by comparing all the different studied groups. DG(14,0/22:1), stearamide, proline, and E,e-carotene-3,3′-dione were found altered in PRE, and their levels returned to those of a baseline control group 3–6 months after surgery. Furthermore, 3-galactosyllactose levels remained altered after intervention in some patients. This study provides unique insights into the metabolic profiles of LC patients after surgery at two different time points by combining complementary analytical methods.Articlehttps://pubmed.ncbi.nlm.nih.gov/37843028https://doi.org/10.1021/acs.jproteome.3c0035610.1021/acs.jproteome.3c00356https://hdl.handle.net/20.500.15037/1364W4387661325enJournal of Proteome Research1535-38931535-39072023-10-162026-06-13T09:55:37Z2026-06-13T09:55:37Z
spellingShingle Metabolomics
Lung cancer
Medicine
Hydrophilic interaction chromatography
Cancer
Internal medicine
Gastroenterology
Surgery
High-performance liquid chromatography
Bioinformatics
Chromatography
Chemistry
Biology
Metabolomics
Lung cancer
Medicine
Hydrophilic interaction chromatography
Cancer
Internal medicine
Gastroenterology
Surgery
High-performance liquid chromatography
Bioinformatics
Chromatography
Chemistry
Biology
Humans
Humans
Humans
Lung Neoplasms diagnosis
Lung Neoplasms diagnosis
Lung Neoplasms diagnosis
Lung Neoplasms surgery
Lung Neoplasms surgery
Lung Neoplasms surgery
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Mass Spectrometry methods
Mass Spectrometry methods
Mass Spectrometry methods
Metabolomics methods
Metabolomics methods
Metabolomics methods
Metabolome
Metabolome
Metabolome
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Metabolomics and Mass Spectrometry Studies
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Hypoxia, and Metabolism
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Lipids, and Metabolism
Saida Sánchez Espirilla
Antonio Pereira‐Vega
Belén Callejón‐Leblic
Isabel Díaz-Olivares
Rafael Santos Santana
Carolina Gotera Rivera
José Luis Gómez‐Ariza
José Luís López-Campos
Ana Isabel Blanco-Orozco
Luis Seijó
María Teresa Nava Rodríguez
Luis Alejandro Padrón Fraysse
Ángeles Herrera-Chilla
Germán Peces‐Barba
Tamara García‐Barrera
Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
title Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
title_full Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
title_fullStr Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
title_full_unstemmed Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
title_short Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent
title_sort untargeted metabolomic study of lung cancer patients after surgery with curative intent
topic Metabolomics
Lung cancer
Medicine
Hydrophilic interaction chromatography
Cancer
Internal medicine
Gastroenterology
Surgery
High-performance liquid chromatography
Bioinformatics
Chromatography
Chemistry
Biology
Metabolomics
Lung cancer
Medicine
Hydrophilic interaction chromatography
Cancer
Internal medicine
Gastroenterology
Surgery
High-performance liquid chromatography
Bioinformatics
Chromatography
Chemistry
Biology
Humans
Humans
Humans
Lung Neoplasms diagnosis
Lung Neoplasms diagnosis
Lung Neoplasms diagnosis
Lung Neoplasms surgery
Lung Neoplasms surgery
Lung Neoplasms surgery
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Mass Spectrometry methods
Mass Spectrometry methods
Mass Spectrometry methods
Metabolomics methods
Metabolomics methods
Metabolomics methods
Metabolome
Metabolome
Metabolome
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Metabolomics and Mass Spectrometry Studies
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Hypoxia, and Metabolism
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Lipids, and Metabolism
topic_facet Metabolomics
Lung cancer
Medicine
Hydrophilic interaction chromatography
Cancer
Internal medicine
Gastroenterology
Surgery
High-performance liquid chromatography
Bioinformatics
Chromatography
Chemistry
Biology
Metabolomics
Lung cancer
Medicine
Hydrophilic interaction chromatography
Cancer
Internal medicine
Gastroenterology
Surgery
High-performance liquid chromatography
Bioinformatics
Chromatography
Chemistry
Biology
Humans
Humans
Humans
Lung Neoplasms diagnosis
Lung Neoplasms diagnosis
Lung Neoplasms diagnosis
Lung Neoplasms surgery
Lung Neoplasms surgery
Lung Neoplasms surgery
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Mass Spectrometry methods
Mass Spectrometry methods
Mass Spectrometry methods
Metabolomics methods
Metabolomics methods
Metabolomics methods
Metabolome
Metabolome
Metabolome
Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Metabolomics and Mass Spectrometry Studies
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Hypoxia, and Metabolism
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research Cancer, Lipids, and Metabolism
url https://pubmed.ncbi.nlm.nih.gov/37843028
https://doi.org/10.1021/acs.jproteome.3c00356
https://hdl.handle.net/20.500.15037/1364
work_keys_str_mv AT saidasanchezespirilla untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT antoniopereiravega untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT belencallejonleblic untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT isabeldiazolivares untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT rafaelsantossantana untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT carolinagoterarivera untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT joseluisgomezariza untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT joseluislopezcampos untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT anaisabelblancoorozco untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT luisseijo untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT mariateresanavarodriguez untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT luisalejandropadronfraysse untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT angelesherrerachilla untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT germanpecesbarba untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent
AT tamaragarciabarrera untargetedmetabolomicstudyoflungcancerpatientsaftersurgerywithcurativeintent